Sunny Pharmtech Inc.(TW:6676)
NT$7.12-0.41 (-5.44%)
TW:6676
Sunny Pharmtech Inc. financials statements
NT$7.12
At close:-0.41 (-5.44%)
Sunny Pharmtech Inc. (6676) Ratios
Sunny Pharmtech Inc. Ratios
TW:6676's free cash flow for Q2 2026 was NT$-96.48M. For the 2026 fiscal year, TW:6676's free cash flow was decreased by NT$-13.45M and operating cash flow was NT$-83.04M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.91 | 2.21 | 4.12 | 1.48 | 2.85 |
| Quick Ratio | 0.61 | 1.46 | 3.25 | 1.22 | 2.26 |
| Cash Ratio | 0.19 | 0.84 | 2.42 | 0.79 | 1.38 |
| Solvency Ratio | -0.27 | -0.06 | 0.11 | -0.09 | -0.15 |
| Operating Cash Flow Ratio | -0.58 | -0.22 | 0.34 | 0.10 | -0.21 |
| Short-Term Operating Cash Flow Coverage | -0.95 | -0.91 | 3.40 | 0.13 | -0.49 |
| Net Current Asset Value | NT$ -400.38M | NT$ -175.82M | NT$ -51.95M | NT$ -246.33M | NT$ 3.52M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.24 | 0.23 | 0.35 | 0.23 |
| Debt-to-Equity Ratio | 0.64 | 0.37 | 0.33 | 0.58 | 0.33 |
| Debt-to-Capital Ratio | 0.39 | 0.27 | 0.25 | 0.37 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.27 | 0.22 | 0.22 | 0.25 | 0.19 |
| Financial Leverage Ratio | 1.86 | 1.52 | 1.43 | 1.68 | 1.42 |
| Debt Service Coverage Ratio | -1.07 | -0.48 | 3.08 | -0.26 | -0.85 |
| Interest Coverage Ratio | -30.65 | -17.97 | -6.41 | -40.91 | -31.29 |
| Debt to Market Cap | 0.21 | 0.10 | 0.07 | 0.20 | 0.11 |
| Interest Debt Per Share | 3.32 | 2.66 | 2.82 | 4.10 | 2.73 |
| Net Debt to EBITDA | -2.28 | -10.38 | 1.75 | -6.30 | -2.14 |
| Profitability Margins | |||||
| Gross Profit Margin | -9.24% | 54.16% | 66.58% | 57.48% | 48.03% |
| EBIT Margin | -125.50% | -35.15% | -12.14% | -46.07% | -70.20% |
| EBITDA Margin | -75.08% | -5.72% | 16.12% | -15.01% | -26.69% |
| Operating Profit Margin | -125.50% | -38.99% | -16.81% | -52.18% | -73.03% |
| Pretax Profit Margin | -119.38% | -37.32% | -14.77% | -47.34% | -72.53% |
| Net Profit Margin | -119.38% | -37.32% | -14.77% | -47.34% | -72.53% |
| Continuous Operations Profit Margin | -119.38% | -37.32% | -14.77% | -47.34% | -72.53% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 95.12% | 95.71% | 87.83% | 90.74% | 99.31% |
| Return on Assets (ROA) | -21.53% | -9.83% | -3.70% | -10.45% | -10.96% |
| Return on Equity (ROE) | -40.01% | -14.90% | -5.28% | -17.56% | -15.52% |
| Return on Capital Employed (ROCE) | -28.08% | -11.46% | -4.50% | -13.90% | -12.32% |
| Return on Invested Capital (ROIC) | -24.45% | -11.11% | -4.46% | -12.09% | -11.72% |
| Return on Tangible Assets | -22.40% | -10.22% | -3.85% | -10.99% | -11.51% |
| Earnings Yield | -14.53% | -4.74% | -1.30% | -6.38% | -5.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.88 | 8.25 | 7.59 | 11.77 | 3.40 |
| Payables Turnover | 33.39 | 11.36 | 5.48 | 12.39 | 5.41 |
| Inventory Turnover | 3.45 | 1.55 | 1.48 | 2.13 | 1.28 |
| Fixed Asset Turnover | 0.25 | 0.38 | 0.37 | 0.33 | 0.25 |
| Asset Turnover | 0.18 | 0.26 | 0.25 | 0.22 | 0.15 |
| Working Capital Turnover Ratio | 2.89 | 1.52 | 1.78 | 1.64 | 0.79 |
| Cash Conversion Cycle | 189.00 | 247.34 | 228.72 | 173.32 | 324.21 |
| Days of Sales Outstanding | 94.10 | 44.24 | 48.10 | 31.01 | 107.23 |
| Days of Inventory Outstanding | 105.83 | 235.24 | 247.17 | 171.76 | 284.41 |
| Days of Payables Outstanding | 10.93 | 32.14 | 66.55 | 29.45 | 67.43 |
| Operating Cycle | 199.94 | 279.49 | 295.27 | 202.77 | 391.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.07 | -0.25 | 0.27 | 0.19 | -0.25 |
| Free Cash Flow Per Share | -1.26 | -0.58 | -0.75 | -1.22 | -1.43 |
| Dividend Paid and CapEx Coverage Ratio | -5.42 | -0.75 | 0.26 | 0.14 | -0.21 |
| Capital Expenditure Coverage Ratio | -5.42 | -0.75 | 0.26 | 0.14 | -0.21 |
| Operating Cash Flow Coverage Ratio | -0.33 | -0.10 | 0.10 | 0.05 | -0.09 |
| Operating Cash Flow to Sales Ratio | -0.63 | -0.09 | 0.09 | 0.07 | -0.14 |
| Free Cash Flow Yield | -9.06% | -2.63% | -2.20% | -6.32% | -6.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.87 | -21.10 | -77.39 | -15.65 | -17.18 |
| Price-to-Sales (P/S) Ratio | 8.22 | 7.88 | 11.33 | 7.42 | 12.45 |
| Price-to-Book (P/B) Ratio | 2.75 | 3.15 | 4.05 | 2.75 | 2.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.04 | -38.05 | -45.38 | -15.83 | -15.40 |
| Price-to-Operating Cash Flow Ratio | -13.08 | -88.81 | 127.56 | 99.21 | -87.37 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | -0.15 | 1.20 | 4.01 | -0.26 |
| Enterprise Value Multiple | -13.22 | -148.16 | 72.04 | -55.72 | -48.81 |
| Enterprise Value | 2.51B | 3.54B | 4.98B | 3.01B | 3.14B |
| EV to EBITDA | -13.22 | -148.16 | 72.04 | -55.72 | -48.81 |
| EV to Sales | 9.93 | 8.48 | 11.62 | 8.36 | 13.02 |
| EV to Free Cash Flow | -13.34 | -40.92 | -46.51 | -17.85 | -16.11 |
| EV to Operating Cash Flow | -15.80 | -95.50 | 130.73 | 111.86 | -91.37 |
| Tangible Book Value Per Share | 4.70 | 6.63 | 7.93 | 6.42 | 7.69 |
| Shareholders’ Equity Per Share | 5.06 | 7.04 | 8.41 | 7.00 | 8.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.70 | 2.81 | 3.00 | 2.60 | 1.77 |
| Net Income Per Share | -2.03 | -1.05 | -0.44 | -1.23 | -1.28 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.95 | 1.06 | 1.22 | 1.03 | 1.03 |
| Research & Development to Revenue | 0.89 | 0.52 | 0.49 | 0.71 | 0.71 |
| SG&A to Revenue | 0.27 | 0.41 | 0.35 | 0.39 | 0.50 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.03 | 0.04 | 0.02 |
| Income Quality | 0.53 | 0.24 | -0.60 | -0.16 | 0.20 |
Currency in TWD
